Figure 5From: Analysis of innate defences against Plasmodium falciparum in immunodeficient miceGraft of HuRBC and markers of inflammation during the immunomodulation protocol. (A) The percentage of HuRBC grafted in mouse peripheral blood was assessed by FACS by using an anti-human glycophorin A antibody, after several co-injections of HuRBC, clo-lip and NIMP-R14 antibody into the peritoneum (black arrows). (B) Cytokines/chemokines were assessed in mouse sera by FACS using the CBA mouse inflammatory cytokines kit. (C) Leukocyte number. (D) CD43- CD62L+ Ly-6C+ inflammatory monocytes were assessed by FACS. Results are means ± SEM of 2 experiments (n = 15 mice).Back to article page